Epithelial cell adhesion molecule expression (CD326) in cancer: a short review
about
Pancreatic cancer stem cell markers and exosomes - the incentive pushAdhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic optionsProstate cancer relevant antigens and enzymes for targeted drug deliveryCirculating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer researchThe biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized careThe use of sensitive chemical antibodies for diagnosis: detection of low levels of EpCAM in breast cancerRapid characterization of candidate biomarkers for pancreatic cancer using cell microarrays (CMAs).Label-free enumeration, collection and downstream cytological and cytogenetic analysis of circulating tumor cellsUse of circulating tumor cell technology (CELLSEARCH) for the diagnosis of malignant pleural effusions.Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signatureDifferential Features of Microsatellite-Unstable Colorectal Carcinomas Depending on EPCAM Expression Status.Epcam, CD44, and CD49f distinguish sphere-forming human prostate basal cells from a subpopulation with predominant tubule initiation capability.Identification of DNA aptamers toward epithelial cell adhesion molecule via cell-SELEX.An Ep-ICD based index is a marker of aggressiveness and poor prognosis in thyroid carcinoma.A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors.An automated high-throughput counting method for screening circulating tumor cells in peripheral bloodNestin predicts a favorable prognosis in early ampullary adenocarcinoma and functions as a promoter of metastasis in advanced cancer.Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicineOverexpression of EpCAM and Trop2 in pituitary adenomasGene expression of mesothelioma in vinylidene chloride-exposed F344/N rats reveal immune dysfunction, tissue damage, and inflammation pathwaysHigh-throughput screening for identification of inhibitors of EpCAM-dependent growth of hepatocellular carcinoma cells.Polymorphisms of EpCAM gene and prognosis for non-small-cell lung cancer in Han Chinese.EpCAM and the biology of hepatic stem/progenitor cellsGenetic variants in the EPCAM gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma with portal vein tumor thrombusInfection of mice with influenza A/WSN/33 (H1N1) virus alters alveolar type II cell phenotype.Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis.EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers.EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer ModelMTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer.An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer.Cytoplasmic EpCAM over-expression is associated with favorable clinical outcomes in pancreatic cancer patients with Hepatitis B virus negative infection.Phenotypic and Molecular Characterization of MCF10DCIS and SUM Breast Cancer Cell Lines.Colorectal cancer biomarkers and the potential role of cancer stem cells.Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profileDetection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions.Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinoma.Exosomal microRNA Biomarkers: Emerging Frontiers in Colorectal and Other Human Cancers.Immune Defense Protein Expression in Highly Purified Mouse Lung Epithelial Cells.EpCAM (CD326) is differentially expressed in craniopharyngioma subtypes and Rathke's cleft cysts
P2860
Q26741215-7171FE6D-1D59-47B0-871E-CBF86D8B1365Q26748666-25C67D44-DF76-42F8-A8F5-A04835EBCB6EQ27013843-CF3E592A-12D7-4F77-B09B-4958CDF2BF7DQ27024191-AB83B876-7607-4CB3-81D2-583FAA3E410AQ28066460-68EF826E-8A05-41A5-9B6B-A169FE9DD638Q28486906-0439F9A9-C5FA-4E84-8995-32D72DAA0BDCQ30534663-96AED899-C04A-468E-84B3-9AD8A02B21AEQ30822582-BDCAEB40-C385-4CEE-9C04-49352F576B87Q33811201-2B56C61A-6D88-410C-8E83-C2A285F2B959Q33911184-2BD28514-AF32-4082-A240-CA88B4FFA04AQ34161939-43B4555F-E755-4B93-9A51-95508BCA0797Q34238517-93838FA4-5EE3-42D3-AC54-241EC32BABB6Q34424322-5616892D-4D73-4C46-A604-873014BB0E6BQ34437810-9065060D-5EE9-4D4B-842C-C1F5D470838EQ34548847-D79567C4-FAF4-41AE-88D5-250CE9C5CF64Q34578347-AB7AD994-DD00-47CF-A40F-42A17C24BB84Q34626101-B0BBF7C1-9443-4CDB-A7B0-39D6E84D9DAFQ34698624-347EAACA-1894-4122-A940-982FF4FD1FFAQ34733193-AC1D3ECB-D2F4-4C97-8375-EAF998B9630EQ34765867-0C31BEB2-F2DF-4F84-8D7C-862A871D670FQ34860322-10FD5BDE-EB06-4F16-B8F4-2578B1D62BADQ35051751-527A5D5F-65E8-4930-94CA-090F5B6A2906Q35086401-56B58B96-714C-4456-AD6A-3CDB39667486Q35144077-5F52740C-316A-464B-B4C9-C97B74D7A909Q35275358-EEBFFCCE-C4AC-450E-B455-4108CDB461A6Q35633814-076B063C-DC48-49E5-9F7D-C402F4F821CDQ35875956-FFCD079E-B722-4F9B-AD16-97EC5E157DC8Q36005675-0749216A-C5AB-4684-A21E-D6705C9D8E44Q36352817-BD3FAA8A-EE8C-495C-864C-C66B49F60D44Q36401886-CCC4B424-D577-4430-BC32-EC5DA56E1A57Q36413078-79BC5A96-ACF7-4B99-A2E2-07CD62506E99Q36511460-26938F82-08F7-468C-837B-B2979E3A12DEQ36582681-D5ACA769-61DD-415F-B62F-B9AAA10115B9Q36646553-BE483C53-C7C9-41DE-8B30-C7783E662F2CQ36687528-E7309B4F-E285-4D36-81AC-14579782EE46Q36772138-8041BBB4-61EE-4365-A3A2-5FCE1B894D75Q37046355-68A05F75-1BB9-4D51-A102-41D6A0493F4CQ37073022-79811E39-0F54-4B35-925E-F9D8A3E4015BQ37088320-F81074E9-013E-4007-BA0E-1C97ADC862C8Q37105120-3202A2FC-530A-472F-960E-0DD9C1A89494
P2860
Epithelial cell adhesion molecule expression (CD326) in cancer: a short review
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Epithelial cell adhesion molecule expression (CD326) in cancer: a short review
@ast
Epithelial cell adhesion molecule expression (CD326) in cancer: a short review
@en
Epithelial cell adhesion molecule expression (CD326) in cancer: a short review
@nl
type
label
Epithelial cell adhesion molecule expression (CD326) in cancer: a short review
@ast
Epithelial cell adhesion molecule expression (CD326) in cancer: a short review
@en
Epithelial cell adhesion molecule expression (CD326) in cancer: a short review
@nl
prefLabel
Epithelial cell adhesion molecule expression (CD326) in cancer: a short review
@ast
Epithelial cell adhesion molecule expression (CD326) in cancer: a short review
@en
Epithelial cell adhesion molecule expression (CD326) in cancer: a short review
@nl
P2093
P3181
P1476
Epithelial cell adhesion molecule expression (CD326) in cancer: a short review
@en
P2093
Anja K Marschner
Carlo Patriarca
Hakan Mellstedt
Roberto Maria Macchi
P3181
P356
10.1016/J.CTRV.2011.04.002
P407
P577
2012-02-01T00:00:00Z